The pregnant women living with hiv antiretroviral therapy coverage for pmtct in Jamaica is now 77%, marking a 1% (1.3%) increase compared to 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Jamaica
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,975
Measure:
%
More indicators for Jamaica
Male unintentional poisoning
0.1
+0.0
(2021)
Female wasting in children
3.1%
+0.4%
(2018)
Female prevalence of HIV
0.5%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar103
+intl dollar3
(2022)
Birth registration
98%
-1.5%
(2017)
Contraceptive modern method prevalence
53.2%
-15.2%
(2022)
Jamaica PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | Value | Change |
|---|---|---|
| 2022 | 77% | +1% |
| 2021 | 76% | +12% |
| 2020 | 64% | -15% |
| 2019 | 79% | +3% |
| 2018 | 76% | -1% |
| 2017 | 77% | +3% |
| 2016 | 74% | 0% |
| 2015 | 74% | +9% |
| 2014 | 65% | +19% |
| 2013 | 46% | 0% |
| 2012 | 46% | 0% |
| 2011 | 46% | -10% |
| 2010 | 56% | +5% |
| 2009 | 51% | -22% |
| 2008 | 73% | +13% |
| 2007 | 60% | +4% |
| 2006 | 56% | +20% |
| 2005 | 36% | +36% |
| 2004 | 0% | 0% |
| 2003 | 0% | 0% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |